April 10, 2018 / 3:50 PM / 3 months ago

BRIEF-Beckman Coulter Diagnostics Announces Worldwide Commercialization Of The Access Sensitive Estradiol

April 10 (Reuters) - Beckman Coulter Diagnostics:

* BECKMAN COULTER DIAGNOSTICS ANNOUNCES WORLDWIDE COMMERCIALIZATION OF THE ACCESS SENSITIVE ESTRADIOL Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below